[1]
2022. Recent findings on molecular alterations in IDH1, TP53, and CASP9 in gliomagenesis. Biomedical Research and Therapy. 9, 10 (Oct. 2022), 5375–5383. DOI:https://doi.org/10.15419/bmrat.v9i10.775.